News | CT Angiography (CTA) | August 28, 2017

Philips to Develop FFR-Angiography in Partnership With HeartFlow

Global collaboration aims to accelerate access to tools to determine extent of coronary artery disease and improve patient care

Philips to Develop FFR-CT in Partnership With HeartFlow

August 28, 2017 — Philips Healthcare and HeartFlow Inc. announced they entered into a collaboration agreement to improve access to diagnostic and planning tools for interventional cardiologists evaluating and treating patients with suspected coronary artery disease (CAD). Under the agreement, Philips will promote the use of the HeartFlow FFR-CT (computed tomography) Analysis in conjunction with Philips' advanced catheters for imaging and assessing measurements of the inside of a patient's coronary arteries. 

The advanced catheters from Philips that will be promoted in conjunction with HeartFlow's technology include Philips' coronary fractional flow reserve (FFR), instant wave-free ratio (iFR) and intravascular ultrasound (IVUS) solutions.

Philips and HeartFlow's commercial collaboration will initially focus on the United States, with the intention to expand joint efforts globally in the near term. The two companies are also exploring further collaborations in diagnostic imaging and advanced informatics.

The HeartFlow FFR-CT analysis is the only commercially available noninvasive technology to provide insight into both the extent of CAD and the impact of the disease on blood flow to the heart. Data from a patient's non-invasive coronary CT angiogram are securely uploaded from the hospital's system to the cloud. HeartFlow leverages deep learning to create a personalized, digital 3-D model of a patient's coronary arteries, which is then analyzed by powerful computer algorithms to evaluate millions of complex equations to simulate blood flow in the model and assess the impact of blockages on coronary blood flow. The HeartFlow FFR-CT analysis technology provides results to the clinician via a secure web interface. To date, more than 13,000 patients have benefitted from the HeartFlow FFR-CT.[1]

In the United States, 16.8 million people are affected by CAD, which develops when the coronary arteries narrow, reducing blood flow to the heart.[2] CAD causes chest pain and heart attack and can lead to death. As part of a standard protocol, many of these patients are referred to the cardiac cath lab where more than half are discharged on medicines or non-treatment. Improvements in the non-invasive space have the potential to allow physicians to safely defer invasive testing, reducing risks to the patient and the overall cost of care for all.

"Our commitment is to transform the patient experience and identify pathways that are personalized, high quality and at a lower price point," said Christopher Barys, business leader of Philips image guided therapy devices. "To address the burden that CAD is placing on healthcare systems and to transform the patient experience, hospitals are focused on adopting new technology that can improve the diagnosis and care of these patients while reducing unnecessary invasive procedures. HeartFlow shares our mission of improving clinical outcomes and, through collaboration, we can advance our goal of helping healthcare providers decide, guide, treat and confirm the right therapy at the point of care."

Exclusive Agreement to Co-develop FFR-CT 

In addition to the commercial collaboration agreement between Philips and HeartFlow, the two companies have entered into an exclusive agreement to co-develop an improved cath lab X-ray angiography image derived FFR or iFR solution, to significantly enhance workflow while improving the diagnosis and subsequent treatment of patients with CAD. he solution will use angiographic imaging to create a derived FFR, similar to FFR-CT technology.

 

"Our collaboration agreement with Philips, which has an integrated solution within cath labs, will help bring HeartFlow's technology to more patients with suspected and potentially life-threatening CAD," said John H. Stevens, M.D., president and CEO of HeartFlow. "We look forward to continuing to address unmet needs in cardiology in collaboration with Philips to further support our goal of improving patient lives and reducing the total cost of care."

Philips' seamlessly integrated solutions, such as CORE IVUS and SyncVision, are valuable tools in the diagnosis of CAD. The HeartFlow FFR-CT analysis, is an additional diagnostic tool that expands clinicians' capabilities.

For more information: www.philips.com/newscenter

 

Related FFR and FFR-CT Content:

What is New in FFR Technology

GE Healthcare, HeartFlow Announce Cardiovascular CT Collaboration for FFR-CT

VIDEO: Implementation and the Science Behind FFR-CT

 

References: 

1. Douglas PS, DeBruyne B, Pontone G., Patel MR, et al. One-year outcomes of FFRCT-guided care in patients with suspected coronary disease: The PLATFORM Study. J Am Coll Cardiol. 2016;68(5),435-45. 

2. www.ncbi.nlm.nih.gov/pmc/articles/PMC2787400/

Related Content

FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR
Technology | Angiography | May 22, 2018
Pie Medical Imaging announced that clinical data on its CAAS vFFR (Cardiovascular Angiographic Analysis Systems for...
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
ACR Urges Stricter Adherence to Lung Cancer Screening Guidelines
News | Lung Cancer | May 21, 2018
A new statement from the American College of Radiology (ACR) asserts that provider non-compliance to lung cancer...
FDA Clears CurveBeam LineUp Weight-Bearing Multi-Extremity CT System

Image courtesy of CurveBeam

Technology | Orthopedic Imaging | May 14, 2018
CurveBeam announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its LineUp Multi-...
PET Imaging Shows Protein Clumping May Contribute to Heart Failure Development
News | PET Imaging | May 11, 2018
A team led by Johns Hopkins University Researchers has discovered that protein clumps appear to accumulate in the...
Northwestern Medicine Mobile Stroke Unit Delivers Life-Saving Care 30 Minutes Sooner
News | Stroke | May 07, 2018
A new data analysis of the Northwestern Medicine Mobile Stroke Unit (MSU) found the specialized ambulance provided life...
Black Rhinoceros at Brookfield Zoo Undergoes Portable CT Scan

Layla the rhinoceros was given what is believed to be the first-ever CT scan of an eastern black rhinoceros at Brookfield Zoo on April 19, 2018. The scanner — a portable, battery-powered, 32-slice Samsung BodyTom — was brought into Layla's habitat. Image courtesy of Kelly Tone/Chicago Zoological Society

Feature | Computed Tomography (CT) | May 04, 2018
On April 19, 2018, Layla, a 7½ -year-old, 2,300-pound eastern black rhinoceros who lives at Brookfield Zoo, underwent...
360 Photos | Angiography | May 03, 2018
A 360 degree view of the newest cath lab at Northwestern Medicine Central DuPage Hospital in Winfield, Ill., located
Guideline updates and clinical research highlight the need for improved understanding of gender differences by clinicians and patients
Feature | Women's Health | May 03, 2018 | By Jeff Zagoudis
Clinical research has revealed men and women often have different presentations for cardiovascular disease (CVD).
In today’s world of flashy new features and complicated equipment, we must remember to stop and ask ourselves, “What is this doing for the patient?”

Image courtesy of Carestream.

Feature | Radiology Business | May 03, 2018 | By Jennifer Kemp, M.D., FACR
As a radiologist in today’s evolving global healthcare landscape, I’m grateful for the innovations in...
Overlay Init